Activist Investor Pushes Snap to Cut Costs and Boost Profits
Activist fund Irenic Capital wants Snap to spin off its smart glasses business, cut jobs, buy back shares, and use AI to improve ad revenue.
NOTRELOAD AI
FDA Moving to Bring Back Popular Injectable Peptides
The FDA is moving to allow compounding pharmacies to produce over a dozen banned injectable peptides. RFK Jr. says he's a big fan and has used them with great results.
Aehr Test Shares Surge on Major New Silicon Photonics Order for AI Data Centers
Aehr Test Systems wins major new customer for high-power FOX-XP wafer-level burn-in systems for silicon photonics in hyperscale AI data centers.
Agios Moves Closer to Fast FDA Approval for New Sickle Cell Pill
Agios is pursuing accelerated FDA approval for mitapivat, a new oral pill for sickle cell disease. The RISE UP trial showed better hemoglobin levels, fewer pain crises, and good safety.
Oppenheimer Sees $1 Billion Potential in Passage Bio’s PBFT02 for FTD
Oppenheimer just started coverage on Passage Bio with an Outperform rating and $30 price target. They call the recent pullback a buying opportunity ahead of key PBFT02 data in H1 2026.
Uber’s Strategic Stake in WeRide Powers World’s First Paid Driverless Taxis in Dubai
Uber reveals 5.82% ownership in WeRide as fully driverless robotaxis start paid operations in Dubai today.